Cargando…
Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients
PURPOSE: The aim of the study was to investigate the incidence of acute kidney injury (AKI) occurring after high-dose methotrexate (HDMTX) administration and the role of type 2 diabetes (T2D) playing in the occurrence of AKI. METHODS: We assessed associations between T2D along with other confounding...
Autores principales: | Wang, Yujia, Wei, Li, Guan, Yi, Wang, Qian, Xie, Qionghong, Hao, Chuanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7655081/ https://www.ncbi.nlm.nih.gov/pubmed/33164656 http://dx.doi.org/10.1080/0886022X.2020.1838926 |
Ejemplares similares
-
Methotrexate Associated Renal Impairment Is Related to Delayed Elimination of High-Dose Methotrexate
por: Yang, Shi-Long, et al.
Publicado: (2015) -
The effects of timing onset and progression of AKI on the clinical outcomes in AKI patients with sepsis: a prospective multicenter cohort study
por: Wang, Meiping, et al.
Publicado: (2023) -
Fotemustine, teniposide and dexamethasone versus high-dose methotrexate plus cytarabine in newly diagnosed primary CNS lymphoma: a randomised phase 2 trial
por: Wu, Jingjing, et al.
Publicado: (2018) -
Remdesivir does not increase risk of AKI or ALI in COVID-19 patients
Publicado: (2022) -
Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection
por: Chen, Zijin, et al.
Publicado: (2021)